New hope in reducing rate of HIV infections in women
There’s good news in the fight against HIV. A new South African study has found that a microbicide gel containing the antiretroviral medication, Tenofovir can significantly reduce the rate of HIV infections. The study included almost 900 volunteers and showed that the gel cut a woman’s chances of being infected by 50 percent after the first year.
Broader trials are still needed to confirm the results. For more, we talk with Naomi Rutenberg, vice president and director of the HIV and AIDS program at the Population Council.
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!